Answer
Oct 01, 2025 - 04:49 AM
Invokamet, which combines canagliflozin and metformin, may cause some weight loss in people with type 2 diabetes. This effect is mainly due to canagliflozin, which helps the body remove excess sugar through urine, and metformin, which can also reduce appetite. However, the amount of weight loss varies among individuals and is usually modest.
